Independent profile. This page is compiled by Ogbogwu from NAFDAC-registered records and public information. Ogbogwu is not affiliated with IPCA Pharma Nigeria, and this listing does not imply any endorsement or partnership.
Where IPCA Pharma Nigeria’s products are made
Our August 2026 copy of the NAFDAC Greenbook records a factory country for 8 of IPCA Pharma Nigeria’s 8 current registrations: 0 made in Nigeria, 8 made abroad. The Greenbook lists IPCA Pharma Nigeria as the registration holder for all of them — the factory can be its own plant, a contract manufacturer, or an overseas partner.
India8
- Glycinorm-80 Tablets · Gliclazide
- HCQS Tablets 200 mg · Hydroxychloroquine
- Laridox-AQ DT · Amodiaquine +2 more
- Laridox-AQ DT Forte · Amodiaquine +2 more
- Larinate-120 Injection · Artesunate
- Lumerax Dispersible 20 mg/120 mg Tablets · Artemether; Lumefantrine
- Zerodol Tablets · Aceclofenac
- Zerodol-CR Tablets · Aceclofenac
About IPCA Pharma Nigeria
IPCA Pharma Nigeria has 8 products registered with NAFDAC for the Nigerian market. The full list below is compiled from the NAFDAC Greenbook — Nigeria's official register of approved products.
Its medicines are strongest in Antimalarials (5 products). Registered brands include HCQS Tablets 200 mg, Laridox-AQ DT and Larinate-120 Injection. Most of its products are registered as tablet and injection formulations. 5 of its products link through to full Ogbogwu drug guides covering uses, dosage, prices, and NAFDAC verification. IPCA Pharma Nigeria is the registration holder rather than the physical maker: the Greenbook records factories abroad for its products (mostly India).
IPCA Pharma Nigeria products registered in Nigeria
All 8 NAFDAC-registered products. Filter by therapeutic area, or search by name or ingredient. Products we have a full guide for link through to uses, dosage, price, and verification.
8 of 8 products
- Laridox-AQ DTAmodiaquine 76.5 mg; Sulfadoxine 250 mg; Pyrimethamine 12.5 mg · Tablet · A4-101235
- Laridox-AQ DT ForteAmodiaquine 153 mg; Sulfadoxine 500 mg; Pyrimethamine 25 mg · Tablet · A4-101236
- Lumerax Dispersible 20 mg/120 mg TabletsArtemether 20 mg; Lumefantrine 120 mg · Tablet · C4-0104
| Product | Active ingredient | Strength | Form | NAFDAC No. |
|---|---|---|---|---|
| Glycinorm-80 Tablets | Gliclazide | 80 mg | Tablet | A4-0761 |
| HCQS Tablets 200 mg | Chloroquine | 200 mg | Tablet | 04-7590 |
| Laridox-AQ DT | Amodiaquine; Sulfadoxine; Pyrimethamine | Amodiaquine 76.5 mg; Sulfadoxine 250 mg; Pyrimethamine 12.5 mg | Tablet | A4-101235 |
| Laridox-AQ DT Forte | Amodiaquine; Sulfadoxine; Pyrimethamine | Amodiaquine 153 mg; Sulfadoxine 500 mg; Pyrimethamine 25 mg | Tablet | A4-101236 |
| Larinate-120 Injection | Artesunate | 120 mg | Injection | A4-101320 |
| Lumerax Dispersible 20 mg/120 mg Tablets | Artemether; Lumefantrine | Artemether 20 mg; Lumefantrine 120 mg | Tablet | C4-0104 |
| Zerodol Tablets | Aceclofenac | 100 mg | Tablet | A4-2257 |
| Zerodol-CR Tablets | Aceclofenac | 200 mg | Tablet | A4-5631 |
IPCA Pharma Nigeria — Frequently Asked Questions
Looking to buy IPCA Pharma Nigeria’s products in bulk?
Tell us what you need and the quantity, and we'll connect you with a verified, NAFDAC-registered source. It's free, with no obligation.
Represent IPCA Pharma Nigeria? Email hello@ogbogwu.com to claim this page or correct anything — product and NAFDAC registration facts stay independently maintained by Ogbogwu.
Are you a manufacturer or importer looking to supply this market? Start here.
Sources
- •NAFDAC Greenbook — the official database of products registered with Nigeria's National Agency for Food and Drug Administration and Control. The product list for IPCA Pharma Nigeria is drawn from active registrations in the Greenbook.
- •Publicly available company information and the company's official website.